Vimarsana
Biggest News Aggregation in the World

Page 5 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Analyst Today - Breaking & Trending Today

GlobalData : Redx will become one of key upcoming players in IPF treatment with FDA's ODD for zelasudil, says GlobalData -Today at 03:07 am - Vimarsana News

GlobalData : Redx will become one of key upcoming players in IPF treatment with FDA's ODD for zelasudil, says GlobalData -Today at 03:07 am

11 Sep, 2023 Redx will become one of key upcoming players in IPF treatment with FDA's ODD for zelasudil, says GlobalData Share ...

Indian pharma cos must raise public awareness on clinical trials: Report - Vimarsana News

Indian pharma cos must raise public awareness on clinical trials: Report

India is seeing an increase in the number of clinical trials initiated by either domestic or multinational pharmaceutical companies in recent years, but awareness about the trials among the public is low, according to a report on Friday.Global ...

Pfizer, Gilead, GSK To Lead $150 Bn Infectious Diseases Mkt By 2029: Report - Vimarsana News

Pfizer, Gilead, GSK To Lead $150 Bn Infectious Diseases Mkt By 2029: Report

New Delhi, July 19 (IANS) Pharma giants Pfizer, Gilead Sciences, and GSK are expected to collectively generate 62 per cent of total infectious disease drug

Pfizer, Gilead, GSK to lead $150 bn infectious diseases mkt by 2029: Report - Vimarsana News

Pfizer, Gilead, GSK to lead $150 bn infectious diseases mkt by 2029: Report

Pharma giants Pfizer, Gilead Sciences, and GSK are expected to collectively generate 62 per cent of total infectious disease drug sales between 2023 and 2029, according to a report on Wednesday.The report by GlobalData, a leading data and ...

Eli Lilly's drug to lead obesity, diabetes treatment: Report - Vimarsana News

Eli Lilly's drug to lead obesity, diabetes treatment: Report

Eli Lilly's Mounjaro is likely to become the leading therapy for obesity and Type-2 diabetes, according to a report on Thursday.Diabetes drug Mounjaro's (tirzepatide) success in completing the second final stage trial for obesity has spiked Eli ...